
News|Articles|June 1, 2010
46th DIA Annual Meeting
Advertisement
46th DIA Annual Meeting
Electronic Health Records: Friend or Foe?
Felix Gyi, PharmD, MBA, CIP, RAC, Chief Executive Officer of Chesapeake Research Review discusses his view on electronic health records including the pros and cons of using EHR within clinical research.
The Foray into Comparative Effectiveness Research
Jeff Goldsmith, PhD, President of Health Futures Inc., Associate Professor of the University of Virginia, and DIA Keynote Speaker, speaks to Managing Editor Kerri Nelen about the benefits of comparative effectiveness research and the stumbling blocks it must overcome.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
Protocol Design Doesn't Fail in the Protocol, It Fails in Transition to Trial
5



